<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CXCR6</id>
	<title>CXCR6 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CXCR6"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CXCR6&amp;action=history"/>
	<updated>2026-05-12T15:56:00Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=CXCR6&amp;diff=6310&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «C-X-C chemokine receptor type 6 (CXC-R6) (CXCR-6) (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD186 antigen) [BONZO] [STRL33]...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CXCR6&amp;diff=6310&amp;oldid=prev"/>
		<updated>2021-05-12T15:23:08Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «C-X-C chemokine receptor type 6 (CXC-R6) (CXCR-6) (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD186 antigen) [BONZO] [STRL33]...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;C-X-C chemokine receptor type 6 (CXC-R6) (CXCR-6) (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD186 antigen) [BONZO] [STRL33] [TYMSTR]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=[[CXCR6]] Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and [[CD4]]  T-Cell-Dependent Control of Senescence.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30710528&lt;br /&gt;
|abstract=Inflammation in the liver provokes fibrosis, but inflammation is also important for tumor surveillance. Inhibitors of chemokine pathways, such as [[CXCL16]] and [[CXCR6]] regulation of lymphocyte trafficking, are being tested as antifibrotic agents, but their effects on the development of hepatocellular carcinoma (HCC) are unclear. We assessed the roles of [[CXCR6]]-dependent immune mechanisms in hepatocarcinogenesis. C57BL/6J wild-type (WT) mice and [[CXCR6]]-deficient mice (Cxcr6 ) were given injections of diethylnitrosamine (DEN) to induce liver cancer and α-galactosylceramide to activate natural killer T (NKT) cells. We also performed studies in mice with conditional, hepatocyte-specific deletion of NEMO, which develop inflammation-associated liver tumors (Nemo  and Nemo Cxcr6  mice). We collected liver tissues from patients with cirrhosis (n = 43), HCC (n = 35), and neither of these diseases (control individuals, n = 25). Human and mouse liver tissues were analyzed by histology, immunohistochemistry, flow cytometry, RNA expression arrays (from sorted hepatic lymphocytes), and matrix-assisted laser desorption/ionization imaging. Bone marrow was transferred from Cxcr6  or WT mice to irradiated C57BL/6J mice, and spleen and liver cells were analyzed by flow cytometry. [[CD4]]  T cells or NKT cells were isolated from the spleen and liver of [[CD4]]5.1  WT mice and transferred into [[CXCR6]]-deficient mice after DEN injection. After DEN injection, [[CXCR6]]-deficient mice had a significantly higher tumor burden than WT mice and increased tumor progression, characterized by reduced intrahepatic numbers of invariant NKT and [[CD4]]  T cells that express tumor necrosis factor and interferon gamma. Livers of Nemo Cxcr6  mice had significantly more senescent hepatocytes than livers of Nemo  mice. In studies of bone-marrow chimeras, adoptive cell transfer experiments, and analyses of Nemo  mice, we found that NKT and [[CD4]] T cells promote the removal of senescent hepatocytes to prevent hepatocarcinogenesis, and that this process required [[CXCR6]]. Injection of WT with α-galactosylceramide increased removal of senescent hepatocytes by NKT cells. We observed peritumoral accumulation of [[CXCR6]]-associated lymphocytes in human HCC, which appeared reduced compared with cirrhosis tissues. In studies of mice with liver tumors, we found that [[CXCR6]] mediated NKT-cell and [[CD4]]  T-cell removal of senescent hepatocytes. Antifibrotic strategies to reduce [[CXCR6]] activity in liver, or to reduce inflammation or modulate the immune response, should be tested for their effects on hepatocarcinogenesis.&lt;br /&gt;
|mesh-terms=* Animals&lt;br /&gt;
* CD4-Positive T-Lymphocytes&lt;br /&gt;
* Carcinogenesis&lt;br /&gt;
* Carcinoma, Hepatocellular&lt;br /&gt;
* Cellular Senescence&lt;br /&gt;
* Diethylnitrosamine&lt;br /&gt;
* Disease Progression&lt;br /&gt;
* Galactosylceramides&lt;br /&gt;
* Hepatocytes&lt;br /&gt;
* Humans&lt;br /&gt;
* Immunologic Surveillance&lt;br /&gt;
* Interferon-gamma&lt;br /&gt;
* Intracellular Signaling Peptides and Proteins&lt;br /&gt;
* Liver Cirrhosis&lt;br /&gt;
* Liver Neoplasms&lt;br /&gt;
* Lymphocyte Activation&lt;br /&gt;
* Male&lt;br /&gt;
* Mice&lt;br /&gt;
* Mice, Inbred C57BL&lt;br /&gt;
* Mice, Knockout&lt;br /&gt;
* Natural Killer T-Cells&lt;br /&gt;
* Receptors, CXCR6&lt;br /&gt;
* Tumor Burden&lt;br /&gt;
* Tumor Necrosis Factor-alpha&lt;br /&gt;
|keywords=* Chemokine&lt;br /&gt;
* Liver Cancer&lt;br /&gt;
* NKT Cells&lt;br /&gt;
* Senescence&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1053/j.gastro.2019.01.247&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>